Cigna CEO Cordani reports new stock awards, withholdings

The Cigna Group Chairman & CEO David Cordani reported new equity awards and related tax withholdings.

Rhea-AI Filing Summary

The Cigna Group Chairman & CEO David Cordani reported new equity awards and related tax withholdings. He was granted 37,516 employee stock options at an exercise price of $0, vesting in three equal annual installments beginning March 1, 2027.

He also acquired 23,788 shares of common stock from settlement of strategic performance shares for the 2023–2025 period and 17,389 restricted shares that vest in three equal annual installments beginning March 1, 2027. To cover tax obligations on these awards, 11,024 and 4,408 shares were disposed of at $287.55 per share. The filing also lists indirect holdings in common stock through a trust, a GRAT, and ongoing participation in The Cigna Group's 401(k) Plan.

Insider Trade Summary

8 transactions reported

Mixed 8 txns

Insider Cordani David

Role Chairman & CEO

Type	Security	Shares	Price	Value
Grant/Award	Employee Stock Option (Right to Buy)	37,516	$0.00	$0.00
Grant/Award	Common Stock, $.01 Par Value	23,788	$0.00	$0.00
Grant/Award	Common Stock, $.01 Par Value	17,389	$0.00	$0.00
Exercise Price or Tax Liability	Common Stock, $.01 Par Value	11,024	$287.55	$3.17M
Exercise Price or Tax Liability	Common Stock, $.01 Par Value	4,408	$287.55	$1.27M
holding	Common Stock, $.01 Par Value	--	--	--
holding	Common Stock, $.01 Par Value	--	--	--
holding	Common Stock, $.01 Par Value	--	--	--

Holdings After Transaction: Employee Stock Option (Right to Buy) — 37,516 contracts (Direct); Common Stock, $.01 Par Value — 47,101 shares (Direct); Common Stock, $.01 Par Value — 157,935 shares (Indirect, By Trust); Common Stock, $.01 Par Value — 440,798 shares (Indirect, By GRAT); Common Stock, $.01 Par Value — 1,792.5915 shares (Indirect, By 401(k))

Footnotes (6)

1. F1. The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2023-2025 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals.
2. F2. These restricted shares vest in three equal annual installments beginning March 1, 2027.
3. F3. Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares.
4. F4. Represents shares withheld to satisfy tax obligations upon vesting of restricted shares.
5. F5. Represents shares acquired through ongoing participation in The Cigna Group's 401(k) Plan.
6. F6. This option vests in three equal annual installments beginning March 1, 2027.

FAQ

What equity awards did Cigna (CI) CEO David Cordani receive in this Form 4?

David Cordani received 37,516 employee stock options and 41,177 shares of Cigna common stock. The shares include 23,788 from strategic performance share settlement and 17,389 restricted shares, both tied to company performance and multi-year vesting schedules.

How do the new Cigna (CI) stock options granted to David Cordani vest?

The 37,516 employee stock options granted to David Cordani vest in three equal annual installments beginning March 1, 2027. This means the options become exercisable over three years, aligning his compensation with Cigna’s longer-term performance and shareholder outcomes.

Why did David Cordani dispose of Cigna (CI) shares in this filing?

Cordani disposed of 11,024 and 4,408 Cigna shares to satisfy tax obligations on equity awards. Footnotes state these shares were withheld upon settlement of strategic performance shares and vesting of restricted shares, rather than sold in an open-market transaction.

What are strategic performance shares referenced in the Cigna (CI) Form 4?

Strategic performance shares are stock awards that settle based on achievement of pre-established company performance goals. Cordani received common stock for the 2023–2025 three-year performance period, with the number of shares determined by actual performance against those Cigna performance targets.

How do David Cordani’s restricted Cigna (CI) shares vest over time?

The 17,389 restricted Cigna shares granted to Cordani vest in three equal annual installments beginning March 1, 2027. Each year, one-third of these restricted shares becomes fully owned, supporting retention and long-term alignment with company performance.

What indirect Cigna (CI) holdings does David Cordani report in this Form 4?

Cordani reports indirect ownership of Cigna common stock through a trust, a GRAT, and The Cigna Group’s 401(k) Plan. These entries reflect shares held in estate-planning and retirement vehicles rather than additional market transactions on the Form 4 date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/03/2026 - 07:16 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Cordani David

(Last) (First) (Middle)

900 COTTAGE GROVE ROAD

(Street)

BLOOMFIELD CT 06002

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Cigna Group [ CI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chairman & CEO

3. Date of Earliest Transaction (Month/Day/Year)
02/27/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, $.01 Par Value	02/27/2026		A		23,788(1)	A	$0	45,144	D
Common Stock, $.01 Par Value	02/27/2026		A		17,389(2)	A	$0	62,533	D
Common Stock, $.01 Par Value	02/27/2026		F		11,024(3)	D	$287.55	51,509	D
Common Stock, $.01 Par Value	02/27/2026		F		4,408(4)	D	$287.55	47,101	D
Common Stock, $.01 Par Value								157,935	I	By Trust
Common Stock, $.01 Par Value								440,798	I	By GRAT
Common Stock, $.01 Par Value								1,792.5915(5)	I	By 401(k)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (Right to Buy)	$287.5475	02/27/2026		A		37,516		03/01/2027(6)	02/27/2036	Common Stock, $.01 Par Value	37,516	$0	37,516	D

Explanation of Responses:

1. The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2023-2025 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals.

2. These restricted shares vest in three equal annual installments beginning March 1, 2027.

3. Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares.

4. Represents shares withheld to satisfy tax obligations upon vesting of restricted shares.

5. Represents shares acquired through ongoing participation in The Cigna Group's 401(k) Plan.

6. This option vests in three equal annual installments beginning March 1, 2027.

Remarks:

	Tyler Gratton, attorney-in-fact	03/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.